Planet Labs PBC quarterly report, Q1 FY2022

Business context and reporting period

Entity mismatch: The supplied filing is DMY Technology Group, Inc. IV’s unaudited Form 10-Q for the quarter ended March 31, 2021, not a Planet Labs PBC filing. It describes a newly formed SPAC seeking a business combination; it does not provide Planet Labs operating or financial results.

DMY IV completed its IPO on March 9, 2021, selling 34.5 million units at $10 each for $345.0 million gross proceeds, and raised another $8.9 million through a private placement of warrants. It had not begun operations or generated revenue by quarter-end.

Financial results and position

  • Revenue: No operating revenue. The filing reports no meaningful operating margin.
  • Loss: Net loss was $14.55 million for the quarter. Operating loss was $322,918; the largest reported expense was a $14.06 million loss on issuance of private placement warrants. A $495,335 gain from changes in warrant fair value partly offset expenses.
  • Cash flow: Operating cash use was $261,333; investing cash use was $345.0 million, principally the Trust Account deposit; financing cash provided was $346.12 million. Ending cash outside the Trust Account was $858,767.
  • Liquidity and assets: Trust Account investments were $345.05 million. Management reported approximately $1.1 million of working-capital deficiency and stated it expected insufficient working capital to meet needs through the earlier of a business combination or one year from the filing.
  • Liabilities and equity: Total liabilities were $47.19 million, including $34.68 million of derivative warrant liabilities and $12.08 million of deferred underwriting commissions. No borrowings under working-capital loans were outstanding. Stockholders’ equity was $5.00 million; $294.33 million of Class A shares were classified as temporary equity due to possible redemption.

The balance sheet is compared with December 31, 2020; the filing provides no prior-year quarterly operating comparison because the company was formed in December 2020.

Material changes, outlook and risks

  • The company was in the process of identifying a target and had to complete a business combination by March 9, 2023, or redeem public shares and wind up. There was no specific target or transaction guidance in this filing.
  • Warrants were reclassified as liabilities following SEC staff guidance. The correction increased derivative liabilities by $21.1 million and reduced Class A shares subject to possible redemption by an offsetting amount on the March 9 balance sheet; the filing says it did not affect financial position overall, net loss, or cash flows.
  • Management reported disclosure controls were not effective at a reasonable assurance level because of a material weakness related to warrant accounting. Management performed additional analyses and said the quarterly statements fairly presented the company’s financial position and results in all material respects.
  • Warrant fair-value changes are noncash, recurring, and could materially fluctuate earnings. The filing also cites possible dilution from future business-combination financing and uncertainty about COVID-19’s effects on the target search and financial position.
  • The company reported no legal proceedings and no off-balance-sheet arrangements. Deferred underwriting commissions are payable only if a business combination is completed.

Important facts for investors to verify

  1. Confirm the filing entity: this is DMY Technology Group, Inc. IV, not Planet Labs PBC.
  2. Reconcile the share count: the financial statements report 29,432,891 Class A shares subject to possible redemption, while MD&A later states 31,055,758.
  3. Review the warrant-liability valuation and material weakness, including subsequent remediation and any later fair-value effects.
  4. Assess cash available outside the Trust Account and whether additional sponsor or working-capital financing was obtained.
  5. Check subsequent filings for a business-combination target, transaction terms, redemptions, and any changes to the March 9, 2023 deadline.